If you've ever left a mammogram appointment with more questions than answers — told to "come back in six months" or that your results were "inconclusive due to dense tissue" — you're not alone. Millions of women across the United States have been in that exact situation. And for a lot of them, the uncertainty that follows is genuinely hard to sit with.

The good news is that breast imaging has come a long way. And one of the most meaningful advances in that evolution is also one that most women haven't heard of yet: the Koning Vera 3D breast CT. It's a different kind of scan entirely — and for women who need more clarity than a traditional mammogram can offer, it changes the conversation significantly.

Why Mammography Sometimes Isn't Enough

Mammography has saved lives. That's not in question. But it's also a technology with real limitations, and those limitations affect specific groups of women more than others.

Women with dense breast tissue, for example, face a compounding challenge. Dense tissue shows up white on a mammogram — and so do many abnormalities. When both the background and the thing you're looking for are the same color, important findings can be obscured. Studies have consistently shown that mammography has lower sensitivity in women with dense breasts, which is why many states now require that women be notified when their tissue is classified as dense.

Women with breast implants face similar imaging challenges. Women who have had prior breast surgeries, who carry genetic mutations like BRCA1 or BRCA2, or who have already had an abnormal mammogram result and need a clearer next-step image — all of them are candidates who may benefit significantly from a more advanced imaging approach.

This is exactly the clinical gap that the Koning Vera 3D breast CT was designed to address.

What the Koning Vera Actually Is

The Koning Vera is a dedicated breast CT system that creates true isotropic 3D images of the breast — meaning every angle, every layer of tissue, is captured and viewable without the overlapping structures that make traditional 2D mammography limited in certain cases. It's FDA-approved with Premarket Approval (PMA), which is the highest level of FDA clearance available for medical devices. This isn't an experimental technology — it's a clinically validated, purpose-built system for breast imaging.

Here's what makes it practically different from what most women have experienced:

There is no compression. The scan takes approximately 10 seconds per breast. The patient lies face-down on a padded table, and the imaging happens quietly and quickly. For women who find traditional mammography physically painful or difficult to tolerate, this alone is a meaningful change.

The radiation exposure is comparable to a standard 2D mammogram — approximately 0.7 mSv for a non-contrast scan — which is roughly 75% less than the average person's annual background radiation exposure. So the improved image quality doesn't come at the cost of increased radiation burden.

And for women who need biopsy guidance, the Koning Vera uses about 50% less radiation than traditional stereotactic biopsy methods.

Who This Scan Is Designed For

The Koning Vera 3D breast CT is currently used as a diagnostic imaging tool — meaning it's typically recommended as a next step after a screening mammogram has raised questions, rather than as a standalone annual screening. That positioning matters, because it clarifies exactly who this technology is for right now.

You may be a strong candidate if you have received abnormal mammogram results that require further evaluation, if you've been told you have dense breast tissue that makes mammography interpretation difficult, if you have breast implants that limit mammography's effectiveness, or if you've been flagged as high-risk due to genetic factors, a history of chest radiation before age 30, or a strong family history of breast cancer.

Women experiencing breast symptoms — a palpable lump, persistent pain, nipple changes, skin changes — and those who have had prior inconclusive imaging results are also strong candidates for this kind of advanced diagnostic imaging.

The clinical term you might hear from your provider is BI-RADS 3 — which indicates a "probably benign" finding that warrants a six-month follow-up. For women in that category, breast CT can often provide the additional clarity needed to either confirm a benign finding or flag something that requires further attention.

The 3D Difference: What It Means Clinically

The distinction between 2D mammography, digital breast tomosynthesis (DBT), and true 3D breast CT imaging matters clinically — and it's worth understanding.

Digital breast tomosynthesis creates a series of 2D slices that are reconstructed into a pseudo-3D view. It's an improvement over standard mammography, but it still requires compression and still has limitations in women with dense tissue or implants.

The breast CT approach is fundamentally different. Because the Koning Vera captures true isotropic 3D images — with equal resolution in all directions — clinicians can review the tissue from any angle without reconstruction artifacts. They can see structures that would be hidden by overlapping tissue in a 2D image. The spatial resolution is high enough to evaluate subtle findings with much greater confidence.

Dr. Etta Pisano, MD, FACR, of the National Cancer Institute, has noted that with this technology, breast cancer has nowhere to hide. That's not hyperbole — it reflects the genuine clinical advantage of imaging that captures the full three-dimensional reality of breast tissue rather than a compressed, flattened representation of it.

How Gnosis for Her Makes This Technology Accessible

One of the persistent challenges in women's health is that the most advanced diagnostic tools tend to cluster in large academic medical centers — accessible to patients with resources, insurance, and proximity, but out of reach for many women who need them just as much.

Gnosis for Her was built specifically to address that gap. Their mobile care unit brings the Koning Vera 3D breast CT directly into communities across Southern California — no hospital, no long wait list, no complicated referral chain. The scan is available at a self-pay price of $499, with a $20 reservation fee applied toward that total. FSA and HSA funds are eligible, and the team is actively working toward broader insurance acceptance.

Results are read by a board-certified radiologist and delivered securely to both the patient and their physician, typically within 72 hours when prior imaging is available.

For women who don't have a primary care provider or who can't get in quickly for a referral, Gnosis for Her has partnered with Karis Healthcare to offer a brief telehealth medical evaluation that can result in the required provider order — so logistical barriers don't become barriers to access.

Taking Charge of Your Breast Health

Breast cancer is one of the most commonly diagnosed cancers in American women. Early detection — real early detection, with imaging that captures what's actually there — is one of the most powerful tools available. When traditional screening leaves questions unanswered, having access to advanced imaging like the Koning Vera 3D breast CT can mean faster answers, clearer decisions, and better outcomes.

If you've been told your mammogram needs a follow-up, if you've been dealing with dense tissue results for years, or if you've simply been putting off imaging because the compression is too painful to tolerate — it's worth knowing that there are better options available.

Speak with your healthcare provider about whether breast CT imaging is appropriate for your situation. And when you're ready to take the next step, visit gnosisforher.com to learn more, take the eligibility quiz, and book your scan at a location in Southern California.